LexDanaLexDanabeta
Inventor

Paul S. Watson

Inventor
Carrboro, NC, US

Overview

20→
Patents
2002–2014
Patent span
Human necessities
Primary field (CPC A)

Patents· 20 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes16%
A61FFilters implantable into blood vessels13%
C07CAcyclic or carbocyclic compounds5%
C07HSugars5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
PatentTitleYear
8,835,457'Bridged bicyclic RHO kinase inhibitor compounds, compositions and use'20148,604,218'Cytoskeletal active rho kinase inhibitor compounds, composition and use'20138,604,205'Cytoskeletal active rho kinase inhibitor compounds, composition and use'20138,476,295'Bridged bicyclic RHO kinase inhibitor compounds, composition and use'20138,158,796'Process for the preparation of Rho-kinase inhibitor compounds'20128,071,779'Cytoskeletal active rho kinase inhibitor compounds, composition and use'20118,039,465'Cytoskeletal active compounds, composition and use'20117,947,850'Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones'20117,943,760'Non-nucleotide composition for inhibiting platelet aggregation'20117,932,376'Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation'20117,741,473'Process for the preparation of 4,6-disubstituted-tetrahydro-furo, thieno, pyrrolo and cyclopenta-[3,4][1,3]dioxoles'20107,666,861'Cytoskeletal active compounds, composition and use'20107,592,445'Non-nucleotide composition and method for inhibiting platelet aggregation'20097,504,497'Orally bioavailable compounds and methods for inhibiting platelet aggregation'20097,414,137'Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones'20087,335,648'Non-nucleotide composition and method for inhibiting platelet aggregation'20087,320,974'Cytoskeletal active compounds, compositions and use'20086,906,066'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'20056,706,735'2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity'20046,441,001'2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2004Based in Middletown, DE, US· patent location history
2005–2014Based in Carrboro, NC, US· patent location history
2008–2013Patents assigned to INSPIRE PHARMACEUTICALS INC (15)· patent assignee history
2011–2014Patents assigned to SLADE DAVID J (6)· patent assignee history
2011–2014Patents assigned to WATSON PAUL S (6)· patent assignee history
2011–2014Patents assigned to LAMPE JOHN W (5)· patent assignee history
2011–2013Patents assigned to DECAMP JONATHAN BRYAN (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
INSPIRE PHARMACEUTICALS INC152008–2013
SLADE DAVID J62011–2014
WATSON PAUL Sself62011–2014
LAMPE JOHN W52011–2014
DECAMP JONATHAN BRYAN42011–2013
Locations
LocationPatentsSpan
Carrboro, NC, US182005–2014
Middletown, Delaware, US22002–2004